MetLife Investment Management’s Verastem VSTM Stock Holding History
Bought
Maintained
Sold
Other funds holding VSTM
AC
RI
DTC
RA
NCM
SCM
MetLife Investment Management's VSTM Position: Q2 2026 in Review
MetLife Investment Management increased its Verastem (VSTM) stake by 80% in Q2 2026, buying an estimated $127K and bringing the position to 59,249 shares worth $226K. The position accounts for ﹤0.01% of the portfolio, ranked #2359.
MetLife Investment Management first reported a position in VSTM in Q2 2018 and has held it in 18 quarters since. The position peaked at $267K in Q2 2021. 157 funds tracked by Wall St. Rank hold VSTM as of Q2 2026.
- MetLife Investment Management held 59,249 shares of Verastem worth $226K as of Q2 2026.
- MetLife Investment Management bought 26,291 Verastem shares in Q2 2026, an estimated $127K.
- Verastem made up ﹤0.01% of MetLife Investment Management's portfolio in Q2 2026, its #2359 holding.
- MetLife Investment Management first reported a position in Verastem in Q2 2018 and has held it in 18 quarters since.
- MetLife Investment Management's Verastem position peaked at $267K in Q2 2021.
- 157 funds tracked by Wall St. Rank held Verastem as of Q2 2026.
Based on MetLife Investment Management's 13F filing for Q2 2026, filed 14 Aug 2026.